Home/TRexBio/Johnston Erwin

JE

Johnston Erwin

Chief Executive Officer

Therapeutic Areas

Immunology Oncology Dermatology Gastroenterology

TRexBio Pipeline

Drug	Indication	Phase
TRB-061	Atopic dermatitis (and other inflammatory diseases)	Phase 1

Leadership Team at TRexBio

Laura Berner, JD, MBA

Chief Operating Officer

Brandon Hants, MBA

Chief Financial Officer

Ariella Kelman, MD

Chief Medical Officer

Ali Zarrin, PhD

Chief Scientific Officer

View full TRexBio profile